Clinical predictors of relapse and severe disease phenotype in children with non-systemic juvenile idiopathic arthritis. [PDF]
Sarısoy D +7 more
europepmc +1 more source
Endocrine dysfunctions as complications and comorbidities of juvenile idiopathic arthritis. [PDF]
Kamińska M +5 more
europepmc +1 more source
Case Report: Treatment of refractory lung disease in systemic juvenile idiopathic arthritis with cyclophosphamide and rituximab combination therapy. [PDF]
Freeman WJ, Rife EC, Cron RQ.
europepmc +1 more source
Synovial fluid potentiates local fibroblasts to drive monocyte activation in juvenile idiopathic arthritis. [PDF]
Schmidt T +8 more
europepmc +1 more source
First Description of Nonlupus Full-House Nephropathy in Systemic Juvenile Idiopathic Arthritis Responsive to High-Dose Tocilizumab. [PDF]
Jacobs L +7 more
europepmc +1 more source
Effectiveness of Canakinumab for First-Line Steroid-Free Treatment in Systemic-Onset Juvenile Idiopathic Arthritis and Juvenile Still Disease. [PDF]
Horneff G +9 more
europepmc +1 more source
Pregnancy outcomes in juvenile idiopathic arthritis: systematic review and meta-analysis. [PDF]
Chaisrimaneepan N +4 more
europepmc +1 more source
Ultrasound to Assess the Temporomandibular Joint of Children With Juvenile Idiopathic Arthritis: A Systematic Review. [PDF]
Chana J +6 more
europepmc +1 more source
Application of a novel Musculoskeletal Ultrasound Sum Score (MUSS) in the follow-up of patients with juvenile idiopathic arthritis. [PDF]
Windschall D +2 more
europepmc +1 more source

